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Background:  Both presence of thin-cap fibroatheroma (TCFA) and Troponin elevation are independent predictors of adverse cardiovascular 
outcome. Yet, their crosslink, which may possibly be mediated by subclinical plaque rupture and distal embolization, has not been described.
methods:  In this prospective, observational study, high-sensitivity Troponin T (hsTnT) was measured and IVUS imaging was performed in a segment 
of a non-culprit coronary artery in 231 patients with stable CAD undergoing elective angiography.
results:  TnT was detectable (>3 pg/mL) in 212 patients (92%) and a concentration above 14 pg/mL was observed in 19.5%. Normalised 
segmental plaque volumes were positively associated with hsTnT levels (25.0 mm3 increase in segmental plaque volume per SD increase in ln-
transformed hsTnT, 95%CI: 6.0-44.0, p=0.010). Higher hsTnT levels were measured in patients with the presence of VH-TCFA (adj. odds ratio [aOR] 
for presence of TCFA = 1.52 per SD increase in ln-transformed hsTnT, 95%CI: 1.10-2.11, p=0.011). Patients with VH-TCFA had a 2-fold increased 
prevalence of hsTnT concentration ≥14 pg/mL (aOR 2.35, 95% CI: 1.12-4.91, p=0.024). In addition, a 3-fold increased prevalence of hsTnT 
concentration ≥14 pg/mL was observed in patients with a VH-TCFA with a lesional plaque volume higher than the median (aOR 3.36, 95%CI: 1.44-
7.84, p=0.005).
conclusion:  Segmental plaque volume and presence of VH-TCFA lesions are associated with higher circulating TnT concentrations in stable CAD 
patients.
 
